BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17355206)

  • 1. Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery.
    Olson KR; Eglen RM
    Assay Drug Dev Technol; 2007 Feb; 5(1):137-44. PubMed ID: 17355206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation.
    Fung P; Peng K; Kobel P; Dotimas H; Kauffman L; Olson K; Eglen RM
    Assay Drug Dev Technol; 2006 Jun; 4(3):263-72. PubMed ID: 16834532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme fragment complementation: a flexible high throughput screening assay technology.
    Eglen RM
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):97-104. PubMed ID: 15090161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R; Seethala R
    J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening using beta-lactamase reporter-gene technology for identification of low-molecular-weight antagonists of the human gonadotropin releasing hormone receptor.
    Oosterom J; van Doornmalen EJ; Lobregt S; Blomenröhr M; Zaman GJ
    Assay Drug Dev Technol; 2005 Apr; 3(2):143-54. PubMed ID: 15871689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of iNOS inhibitors using InteraX.
    Mallinder PR; Wallace AV; Allenby G
    J Biomol Screen; 2009 Mar; 14(3):263-72. PubMed ID: 19211775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fluorescent proteins for high-content screening.
    Wolff M; Wiedenmann J; Nienhaus GU; Valler M; Heilker R
    Drug Discov Today; 2006 Dec; 11(23-24):1054-60. PubMed ID: 17129823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporter gene assays in Candida albicans.
    Sturtevant J
    Methods Mol Biol; 2009; 499():157-67. PubMed ID: 19152047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A miniaturized glucocorticoid receptor translocation assay using enzymatic fragment complementation evaluated with qHTS.
    Zhu PJ; Zheng W; Auld DS; Jadhav A; Macarthur R; Olson KR; Peng K; Dotimas H; Austin CP; Inglese J
    Comb Chem High Throughput Screen; 2008 Aug; 11(7):545-59. PubMed ID: 18694391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-based liver microsomal assay for screening of pharmaceutical reactive metabolites using a glutathione conjugated 96-well plate.
    Ma X; Chan EC
    Bioconjug Chem; 2010 Jan; 21(1):46-55. PubMed ID: 19957910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to in-cell detection of protein activity: genetically encoded chemiluminescence probes pave the way to robust HTS assays.
    Hodgson L
    ACS Chem Biol; 2008 Jun; 3(6):335-7. PubMed ID: 18570352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-based assays.
    An WF
    Methods Mol Biol; 2009; 486():97-107. PubMed ID: 19347618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence.
    Wehrman TS; von Degenfeld G; Krutzik PO; Nolan GP; Blau HM
    Nat Methods; 2006 Apr; 3(4):295-301. PubMed ID: 16554835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of beta-galactosidase enzyme complementation technology as a high throughput screening format for antagonists of the epidermal growth factor receptor.
    Graham DL; Bevan N; Lowe PN; Palmer M; Rees S
    J Biomol Screen; 2001 Dec; 6(6):401-11. PubMed ID: 11788058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of G-protein coupled receptor modulators using homogeneous cAMP assays.
    Bassoni DL; Jafri Q; Sastry S; Mathrubutham M; Wehrman TS
    Methods Mol Biol; 2012; 897():171-80. PubMed ID: 22674165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanide-based luminescent assays for ligand-receptor interactions.
    Handl HL; Gillies RJ
    Life Sci; 2005 Jun; 77(4):361-71. PubMed ID: 15894006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Content Reporter Assays.
    Cook E; Hermes J; Li J; Tudor M
    Methods Mol Biol; 2018; 1755():179-195. PubMed ID: 29671271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fluorescence polarization in HTS assays.
    Huang X; Aulabaugh A
    Methods Mol Biol; 2009; 565():127-43. PubMed ID: 19551360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.